Breaking the ground for WuXi STA’s new pharmaceutical facility in Delaware
WuXi AppTec subsidiary and leading CRDMO, WuXi STA, has broken the ground at the site for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware.
WuXi STA, a subsidiary of WuXi AppTec based in Shanghai, China, have broken the ground for their latest 190-acre pharmaceutical manufacturing campus in Middletown Delaware. The project was announced in June 2021 and promises WuXi STA’s second facility in the United States to offer expanded capacity and greater flexibility for their customers.
The new, state-of-the-art facility will offer approximately 500 full-time jobs by 2026, and provide a site for formulation development, clinical and commercial drug product manufacturing services in addition to packaging, labelling and storage and distribution for clinical trial and commercial drug materials and products. With 12 sites across the United States, Europe, and Asia, WuXi STA hopes to continue offering their services across the globe.
WuXi STA specializes in pharmaceutical development and manufacturing capabilities, offering solutions for integrated chemical, manufacturing, and controls as a premier CRDMO. Parent company WuXi AppTec operates with a global portfolio of research and development and manufacturing services for the pharmaceutical and healthcare industries to advance discoveries and manufacturing, delivering essential therapies to patients.
Delaware Governor John Carney commented: “The biopharmaceutical industry is part of Delaware’s DNA… Over the next 5 years, WuXi STA plans to build a state-of-the-art pharmaceutical manufacturing campus in one of Delaware’s fastest-growing communities, bringing with it good jobs and economic growth.”
Minzhang Chen, co-CEO of WuXi AppTec and CEO of WuXi STA, added: “I would like to thank our federal, state, and local partners in Delaware for their continued support in the establishment of this site… WuXi STA continues to increase our capabilities and capacities to better serve our customers through a more robust and reliable supply chain. With our integrated contract research, development, and manufacturing organization platform and proven quality system, we look forward to working with our customers to swiftly deliver their innovative therapies to market in order to save lives and improve healthcare for patients.
Source: WuXi STA (stapharma.com)
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance